Seeking Progress

To Potentially Help Slow Disease Progression

A Clinical Research Study for People with Early-Stage Parkinson’s

If you are over 50 and have been diagnosed with Parkinson's disease (PD) within the last 3 years, the PROSEEK Study may be an option. It is a clinical research study evaluating a once-daily, oral investigational drug designed to potentially help slow disease progression in people with early-stage PD.

Take our brief online questionnaire to see if you may be eligible to participate.

Please note: The investigational drug is not approved by Health Authorities including the US Food and Drug Administration (FDA) for the treatment of Parkinson’s disease or any other disease.